To investigate the specific effect of microglial Kv1.3 on epilepsy, we assessed seizure severity and latency by observing neurobehaviors after treatment of PAP-1, a specific blocker of the Kv1.3 channel (Figure 2A). The gene discussed is KCNA3; the disease is epilepsy.